Stock listing

NASDAQ:RPTX Repare Therapeutics Inc Stock

Follow Repare Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:RPTX

$2.65 USD

Close on Jan 27, 2026 · No longer trades

Jun 19, 2020 to last close -91.4% · weekly closes, Jun 19, 2020 – Jan 27, 2026
Lowest – highest close
$0.90 – $44.46 USDSince Jun 19, 2020 · lowest Apr 10, 2025 · highest Jan 7, 2021

Delisted NASDAQ:RPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RPTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Repare Therapeutics Inc on 6ix

Decks
4 decks · latest Dec 12, 2024

Decks

DeckKindSlidesDate
Technical Presentation (December 2024)Technical47 slidesDec 12, 2024
Investor Presentation (May 2024)Investor deck47 slidesMay 7, 2024
Investor Presentation (October 2023)Investor deck33 slidesOct 13, 2023
Technical Presentation (October 2023)Technical47 slidesOct 13, 2023

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Bonita
Other companies: Windward Bio Group AG (Director · Since at least Nov 16, 2026); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); ImageneBio, Inc. (Director · Since at least Mar 25, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); SI-BONE, Inc. (Director · Oct 16, 2018 – Oct 19, 2018 · Past); Tricida Inc (Director · Jun 27, 2018 – Nov 22, 2022 · Past); Loxo Oncology Inc (Director · Jul 31, 2014 – Dec 8, 2017 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – May 15, 2014 · Past)
Director · Jun 18, 2020 – Jun 17, 2024 · Past
Briggs Morrison
Other companies: CRISPR Therapeutics AG (Director · Since at least Jun 5, 2025); Werewolf Therapeutics, Inc. (Director · Since at least Apr 29, 2021); Arvinas, Inc. (Chair of the Arvinas Board of Directors · Since at least Sep 26, 2018); Carisma Therapeutics, Inc. (Director · Mar 7, 2023 – Jun 26, 2024 · Past); Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 17, 2021 · Past); Oncorus Inc (Director · Oct 1, 2020 – Oct 1, 2020 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 11, 2020 · Past); Syndax Pharmaceuticals, Inc. (Director · Mar 2, 2016 – Feb 7, 2024 · Past)
Director · Jun 18, 2020 – Jun 17, 2024 · Past
Ann D. Rhoads
Other companies: QuidelOrtho Corporation (Director · Since at least May 27, 2022); Iteos Therapeutics Inc (Director · Since at least Jul 23, 2020); Globus Medical, Inc. (Director · Since at least Aug 2, 2012); Forty Seven Inc (Chief Financial Officer · Jun 27, 2018 – Apr 7, 2020 · Past); IRIDEX Corporation (Director · Jul 18, 2017 – Jun 13, 2018 · Past); Evoke Pharma Inc (Director · Sep 24, 2013 – May 5, 2021 · Past); Zogenix Inc (EVP, CFO, Treasurer & Sec. · Nov 22, 2010 – Mar 14, 2016 · Past)
Director · Since at least Jun 18, 2020
Todd Foley
Other companies: Aktis Oncology, Inc. (Co-founder and Chairman · Since at least Jan 8, 2026); Entrada Therapeutics, Inc. (Director · Oct 28, 2021 – Jun 2, 2022 · Past); Turmeric Acquisition Corp (President · Oct 15, 2020 – Oct 15, 2020 · Past); Rhythm Pharmaceuticals, Inc. (Director · Oct 4, 2017 – Mar 15, 2021 · Past); Chiasma Inc (Director · Jul 15, 2015 – Aug 5, 2021 · Past); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Feb 4, 2014 · Past); EPIRUS Biopharmaceuticals Inc (Director · Dec 21, 2009 – May 23, 2012 · Past)
Director · Jun 18, 2020 – Jun 8, 2023 · Past
Carol A. Schafer
Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Insmed Incorporated (Director · Since at least May 12, 2021); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past); Aceragen Inc. (Director · Oct 1, 2020 – Jun 23, 2022 · Past)
Director · Since at least May 13, 2021
Samarth Kulkarni
Other companies: Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Black Diamond Therapeutics, Inc. (CEO, CRISPR Therapeutics AG · Since at least Jan 29, 2020); CRISPR Therapeutics AG (Chief Executive Officer and Chairman of the Board · Since at least Oct 18, 2016)
Director · Jun 18, 2020 – Jun 17, 2024 · Past
Susan Molineaux
Other companies: Geron Corporation (Director · Since at least Sep 26, 2012); Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 3, 2023 · Past); Theravance Biopharma, Inc. (Director · Apr 22, 2015 – Apr 27, 2021 · Past); Calithera Biosciences, Inc. (PRESIDENT & CEO, Director · Oct 1, 2014 – Jan 23, 2023 · Past)
Director · Jun 8, 2023 – Jun 17, 2024 · Past
Davis Jerel
Other companies: Turnstone Biologics Corp. (Director · Since at least Jul 20, 2023); LENZ Therapeutics, Inc. (Director · Feb 16, 2021 – Jul 19, 2023 · Past); Aduro Biotech Inc (Director · Oct 5, 2020 – Aug 11, 2023 · Past)
Director · Jun 18, 2020 – Dec 29, 2022 · Past
Steven H Stein
Other companies: Incyte Corporation (CMO & Head of Late-Stage Dev. · Since at least May 2, 2016); Theseus Pharmaceuticals Inc (Director · Oct 17, 2022 – Feb 14, 2024 · Past); Kura Oncology, Inc. (Director · Jan 3, 2017 – Jun 21, 2022 · Past)
Director · Jun 17, 2024 – Jun 17, 2024 · Past
Thomas Civik
Other companies: Pyxis Oncology, Inc. (Chief Executive Officer and Chairman of the Board · Since at least Oct 7, 2021); Five Prime Therapeutics Inc (President and CEO, Director · Apr 13, 2020 – Apr 16, 2021 · Past); Foundation Medicine Inc (Chief Commercial Officer · Nov 13, 2017 – Jul 31, 2018 · Past)
Director · Since at least Sep 7, 2021
All 15 people
PersonSeat
Maria Koehler
Other companies: ImageneBio, Inc. (Director · Apr 15, 2021 – Jun 7, 2024 · Past); ARS Pharmaceuticals, Inc. (Director · Mar 12, 2021 – Jun 10, 2022 · Past)
EVP, CHIEF MEDICAL OFFICER · Jun 18, 2020 – Mar 12, 2025 · Past
Lloyd M. Segal
Other companies: Aktis Oncology, Inc. (INDEPENDENT DIRECTOR · Since at least Jan 8, 2026)
PRESIDENT AND CEO, Director · Jun 18, 2020 – Mar 12, 2025 · Past
Michael ZindaEVP, CHIEF SCIENTIFIC OFFICER · Dec 16, 2020 – Mar 12, 2025 · Past
Sandra Isabelle Barros AlvesSVP, Finance and CAO · Since at least Mar 31, 2025
Steve ForteEVP, CHIEF FINANCIAL OFFICER · Since at least Jun 18, 2020

Open People

Log in to ask 6ix AI your own questions about Repare Therapeutics Inc.